Background and objectives Ambulatory BP monitoring (ABPM) allows a better risk stratification than office BP in hypertensive patients. However, the clinical relevance of ABPM has not been extensively investigated in the CKD population.
Introduction
BP fluctuates diurnally and seasonally. In epidemiologic studies, office BP has been used as representative BP. Despite its fluctuating nature, the office BP was identified as the most important risk factor for cardiovascular diseases. It dates back to the Framingham Heart Study (1-3) for the BP to be named as the risk factor, and as the study continues to the third generations of the participants, BP was controlled at ever lower levels (4) . In the past decade, BP has frequently been discussed in association with CKD (5) (6) (7) .
Because the concepts of masked hypertension (MHT) and white-coat hypertension (WCHT) are well recognized (8) (9) (10) , studies measured only by the office BP are thought to be insufficient. At the same time, parameters derived from ambulatory BP monitoring (ABPM) have been reported to serve as predicting factors for various organ failures (11) (12) (13) (14) (15) . In particular, the association between circadian variations in BP and cardiovascular events has been studied from various approaches (12, (16) (17) (18) (19) (20) .
The Chronic Kidney Disease Japan Cohort (CKD-JAC) observational study was started in 2007 to investigate CKD among Japanese adults and 2977 participants were enrolled (21, 22) . For each patient, ABPM was performed once at the start of the study. The purpose of this study is to describe the characteristics of BP in CKD patients using registration data and to evaluate the background factors that influence ABPM data.
30 minutes for a 24-hour period with the TM-2421 device (A&D Company Limited, Tokyo, Japan). Each patient took the device home and began measurements at their convenience. ABPM data were collected on 1117 patients. Every patient's ABPM data was visually checked to detect inadequate data, including outliers, and 34 patients were determined to be invalid participants. Duplication was seen in two patients, and six patients withdrew consent. Therefore, 1075 patients were available for analysis (Supplemental Figure 1) .
A simple questionnaire was completed by each patient at the time of the ABPM, and the questionnaire collected information such as the time the patient went to bed, the time the patient got up, the frequency of waking up to use the lavatory, and information about how the monitoring affected sleep. Night-time was defined as actual sleep time using the patient's diary. The International Continence Society defined nocturia as a complaint that an individual has to wake $1 times at night to void (23) . However, there are relatively large individual differences between the frequency of night-time urination and the level of complaints. For this study, nocturia was defined as when the patient awakens for urination $3 times during a night (20th higher percentile). Quality of sleep was rated on a four-category scale from "as usual" to "much difficulty sleeping."
Nocturnal BP Change and Its Patterns
The degree of nocturnal BP change (NBPC) was calculated by the following equation:
degree of NBPC ¼ 1003ð½mean daytime systolic pressure 2 ½mean nocturnal systolic pressureÞ=½mean daytime systolic pressure
Patients with NBPC .10% and ,20% were classified as "dippers," .20% as "extreme dippers," 0% to ,10% as "nondippers," and ,0% as "risers." These cutoff points are based on the guidelines for ABPM by the Japanese Circulation Society (24) as well as a previous study (12) .
Morning BP Change
Morning systolic BP (SBP) was the average of SBP during the first 2 hours after awakening time (four SBP readings). The lowest SBP was the average SBP of three readings centered on the lowest night-time reading. Morning BP change (MBPC) was defined as the morning SBP minus the lowest SBP.
Specification of the Season for ABPM
The season for ABPM was divided into summer and winter according to the data from the Chronological Scientific Tables by the National Astronomical Observatory of Japan. The season was determined as summer if the mean monthly temperature in the region of the participating facility was .20°C, and as winter when the temperature was ,20°C.
Office BP Measurement
All of the BP measurements were performed by an automated sphygmomanometer after 5 minutes of rest. Three consecutive seated readings were recorded. In our analysis, office BP was the mean of these three readings.
Diagnostic Criteria for Hypertension
A diagnosis of hypertension was made if the office BP was .140/90 mmHg or 24-hour average BP from ABPM was .130/80 mmHg, based on the Japanese Society of Hypertension guidelines (25) .
Definitions of WCHT, MHT, and Persistent Hypertension
We classified hypertension using thresholds of office BP of 140/90 mmHg and 24-hour average BP of 130/80 mmHg. WCHT is the office BP $140/90 mmHg and Data are presented as n (%) unless otherwise indicated. Hypertension is classified into the above-listed four patterns, using thresholds of office BP of 140/90 mmHg and 24-hour average BP of 130/80 mmHg. The P value for general association is the general correlation between row and column, and it means a rough indication of correlation between background factors and these BP patterns. The ratio of BP patterns and background factors such as CKD stage, sex, antihypertensive medication use, diuretic use, obesity, proteinuria, diabetes, and season were analyzed. 
Renal Function
Serum creatinine from single blood sampling at baseline was measured at a central laboratory and estimated GFR (eGFR) was calculated by the following equations (26) 
Statistical Analyses
Continuous variables from two groups were compared with t tests, and ANOVA was used for comparisons among $3 groups. For multiple comparisons, tendencies were explored by ANOVA with linear contrast. For categorical variables, chi-squared tests (232 contingency table), or Cochran-Mantel-Haenszel tests (m3n table) were performed when there were additional categories.
Simple linear regression analysis or the chi-squared test were used for univariate evaluations to investigate the relation between ABPM parameters and patient questionnaires (night urination times and sleep quality), season for ABPM, and baseline characteristics (sex, age, body mass index [BMI], overweight, eGFR, CKD stage, antihypertensive medicine use, diuretic use, and systolic and diastolic BP). Multiple regression analyses were used for multivariate evaluations including variables with P values ,10% explored above. All statistical analyses were performed by using the SAS software program for Windows (version 9.2; SAS Institute Inc, Tokyo, Japan). Office BP and 24-Hour Average BP Figure 1 shows the scatter plot of office and 24-hour average systolic BP (SBP). The coefficients of correlation were 0.50 for SBP (P,0.001) and 0.52 for diastolic BP (DBP) (P,0.001). Based on office BP, 31.6% of all participants were diagnosed as having hypertension. Based on the 24-hour average BP, 56.9% were diagnosed as having hypertension. Our results showed that 30.9% of patients Multiple regression analysis was performed for multivariate evaluations including sex, other variables with P value ,10% explored in Table 3 , and patients' questionnaire variables as independent variables. As for renal function, we adopted eGFR instead of CKD stages. We did not incorporate proteinuria into this model. ABP, ambulatory BP; BMI, body mass index; eGFR, estimated GFR.
Results

Demographics
had MHT, 5.6% had WCHT, and 26.0% had PHT, whereas 37.6% had well controlled BP. The median interval between the office BP measurement and ABPM was 41 days (25th percentile, 0 days; 75th percentile, 154 days). We divided the patients into two groups by the 75th percentile value, and analyzed for the patterns of hypertension. However, we did not observe any difference between them (data not shown). We evaluated the relationship between hypertension patterns and background factors ( Table 2) . As for the CKD stage, prevalence of normal BP decreased from 42.3% to 29.0%, and that of PHT rose from 21.7% to 36.1% with advancing CKD stage. The prevalence of WCHT was little associated with factors of clinical interest excluding diabetes and the season. The prevalence of MHT and PHT was higher in men than women and in winter than in summer.
Incidence of MHT and PHT was high in patients with diabetes or overweight.
We also evaluated the difference between office BP and ambulatory BP (ABP) as a continuous variable (Tables 3  and 4) , and diabetes, antihypertensive medicine use, and low eGFR accounted for the difference between them. Proteinuria was not associated significantly with the difference between office BP and ABP in another multivariate model (Supplemental Table 1 ).
Characteristics of NBPC
NBPC patterns were analyzed ( Table 5 ). Prevalence of nondippers and risers was lower at stage 3 than at stages 4 and 5. Prevalence of nondippers or risers was markedly high among the patients with much difficulty sleeping (P=0.02) and among the patients with nocturia (P,0.001). In general, there are two methods to separate the daytime period and night-time period: the patient diaries and the short-window setting. In this study, we adopted the former. We checked whether the ratio of NBPC patterns changed according to these two definitions; however, there was a slight difference (data not shown). Our results showed that 290 patients underwent ABPM in summer, whereas there were 785 patients in winter. The 24-hour average BP was higher during winter than during summer. The prevalence of nondippers or risers was higher during summer than winter.
As for other baseline factors, diabetes was a significant variable on NBPC. The prevalence of nondippers or risers was higher among diabetic patients than among nondiabetic patients.
Univariate regression analyses were also performed in an attempt to identify factors associated with NBPC as a continuous variable. Table 6 shows that the significant factors were antihypertensive medication use, diuretic use, diabetes, proteinuria, nocturia, much difficulty in sleep, season, age, and renal function (eGFR and CKD stage).
We performed multivariate regression analyses with the NBPC as a dependent variable and the above-mentioned factors as independent variables, stratifying the participants according to nocturia (Figure 2 ). In the nocturia-negative group, CKD stage 4 (relative to stage 3), diabetes, and season (winter) were identified as significant, and CKD stage 5 relative to stage 3, much difficulty in sleep, and diuretic use also tended to reduce the NBPC. In the nocturia-positive group, neither CKD stage nor sleep quality was a significant independent variable. Only diabetes was significant. Proteinuria was not significantly associated with NBPC in a multivariate model (Supplemental Table 2 ).
MBPC
We performed univariate regression analyses to clarify which factors were associated with MBPC. Age, BMI, overweight, obesity, and season were found to be significant variables (Table 7) . Next, we performed multivariate regression analyses with the above-mentioned factors as independent variables (Table 8 ). BMI was selected as representative of obesity-related variables and eGFR as representative renal function-related variables. MBPC became larger with advancing age and higher BMI. MBPC tended to become larger in winter than summer. For patients with diabetes, MBPC is smaller than in patients without diabetes.
Discussion
Office BP and 24-Hour Average BP The majority of participants had hypertension and proteinuria but the mean BP was normal (132/76 mmHg) and .90% of participants were treated with angiotensin converting enzyme inhibitors/angiotensin receptor blockers (22) . However, the large SD of mean office BP suggested the presence of patients with relatively poorly controlled BP.
In ABPM studies, the 24-hour average BP was the first parameter to be examined (27) . WCHT accounted for 5.6% of all participants. Its prevalence has been reported to be 13% (10, 28) or 18% (29) among the population in general. Bangash and Agarwal performed a meta-analysis of CKD patients (six trials, reported from 2005 to 2008) and reported that the prevalence was 18.3% (10.5%-31.7%) (30) and 15% among CKD cohort (31) . Compared with these previous data, the prevalence of WCHT in this study was very low. There is no consensus on the prognosis of WCHT (32) . Some investigators have reported that WCHT is likely to shift to PHT (33) or that the risk for stroke does not differ between WCHT and PHT, whereas other investigators have reported that the incidence of stroke is significantly lower among patients with WCHT (34) .
In this study, about 30% of all participants had MHT. The prevalence of MHT varies considerably among different reports: Ohkubo et al. (35) . The percentage of MHT in this study was relatively high compared with these previous reports except for the African American Study of Kidney Disease and Hypertension. The prognosis of MHT is poor according to many reports (10,28,36-38) . If the diagnosis of hypertension relies only on office BP, many patients who require treatment may be overlooked. The factors that increased the difference between office BP and ABP were renal function, diabetes, and antihypertensive medicine use including diuretic use. This means that we are unable to control BP of patients with CKD, diabetes, and hypertension only by office BP. Quality of sleep, nocturia, and season did not have a large effect on the difference.
NBPC and CKD Stage
The findings of the relationship between NBPC and CKD stage were approximately equal to our predictions. The percentage of patients showing a nondipper or riser pattern was higher at stages 4 and 5 than at stage 3. However, there was no linear increase in the percentage of those two patterns with advancing CKD stages (data not shown). When evaluating NBPC as a continuous variable, we were not able to find the tendency that the degree of nocturnal fall became small with advancing CKD stage or eGFR decrease (Supplemental Table 3 ).
Factors Associated with NBPC
Quality of sleep has been suggested to affect the NBPC (39) . Quality of sleep and the frequency of urination at night were evaluated in this study. Both appear to influence the pattern of the nocturnal BP decrease markedly. They can be collected by simple questionnaire and they are useful when interpreting NBPC and its patterns.
We also observed a seasonal effect on NBPC. The significantly higher percentage of patients showing an insufficient nocturnal BP decrease during summer than winter was contradictory to our anticipation. However, the MBPC was more marked during winter. This suggests that some of the patients who were classified as showing a sufficient nocturnal BP decrease had MBPC. The degree of MBPC was also greater during winter (19.5 mmHg in summer versus 24.0 mmHg in winter; P,0.001). If a goal is to achieve good BP control throughout the day, it seems essential to note the seasonal effect on diurnal BP variation.
From the multiple regression analysis with NBPC as a dependent variable and nocturia as a stratifying factor, CKD stage 4 (relative to stage 3), diabetes, and season (winter) were identified as significant variables in the nocturia-negative group, and CKD stage 5 (relative to stage 3), much difficulty in sleep, and diuretic use tended to have the same effect on NBPC (Figure 2A) . However, the results differed considerably in the nocturia-positive group. Season and diabetes remained significant factors, but the influence of sleep status and CKD stage was not significant in this group ( Figure 2B ). When using eGFR as an independent variable instead of CKD stage, it remained significant in the nocturia-negative group (Supplemental Table  3 ). In this analysis, the nocturia was used as a stratifying factor rather than as an independent variable for the following reasons: the NBPC will inevitably decrease if the patient is getting up frequently during the night for urination, nocturia is likely to develop as CKD stages advance, and the quality of sleep is also associated with nocturia. These results suggest that this way of patient stratification was rational. The results also suggest that when interpreting the ABPM data, identifying nocturia is essential.
For reference, we evaluated multiple regression models with/without nocturia (Supplemental Table 4 ). In model 2, nocturia had a largest slope among independent variables. R 2 values were 0.05 (model 1) and 0.08 (model 2), that is, nocturia increased the R 2 value nearly 50%. The R 2 was very small due to wide variation of NBPC, but this result showed that nocturia was a very important variable when interpreting ABPM data.
MBPC
MBPC is smaller in patients with diabetes than in patients without diabetes. Renal function was not significant. This is probably due to various interventions to the lifestyle of patients with diabetes or advancing CKD, including drugs. In other words, a reversal of cause and effect might be happening here.
Summary
In this study, we confirmed that the prevalence of PHT was high in the CKD population and increased in association with progression of CKD. The difference in office BP and ABP was increased by diabetes, taking antihypertensive medications, and low eGFR. Various background factors such as eGFR, diabetes, antihypertensive medication use, BMI, and season accounted for abnormal BP patterns in CKD patients. A longitudinal study with use of CKD-JAC data will elucidate the relationship between nondippers, risers, MBPCs, and cardiovascular outcomes. Morning BP change is defined as the difference between morning SBP (the average of SBPs during the first 2 hours) minus the lowest SBP (the average SBPs of three readings centered on the lowest night-time readings). Simple linear regression analysis was used for univariate evaluations to detect the factors associated with morning BP change. BMI, body mass index; eGFR, estimated GFR. Multiple regression analysis was performed for multivariate evaluations. Model includes variables with P value ,10% explored in Table 7 and variables of clinical interest. BMI is selected as the representative of obesity-related variables such as overweight (BMI $25), obesity (BMI $30), and BMI. BMI, body mass index; eGFR, estimated GFR.
